4//SEC Filing
Oxtoby Andrew 4
Accession 0000899243-20-012853
CIK 0001631650other
Filed
May 11, 8:00 PM ET
Accepted
May 12, 5:20 PM ET
Size
5.9 KB
Accession
0000899243-20-012853
Insider Transaction Report
Form 4
Oxtoby Andrew
Chief Commercial Officer
Transactions
- Award
Common Stock, $0.0001 par value
2020-05-10+2,420→ 27,435 total
Footnotes (3)
- [F1]These shares represent restricted stock units ("RSUs") and will be settled in common stock upon vesting. The RSUs vest as to 100% of the underlying shares on September 11, 2020 (the "Vesting Date"), subject to the Reporting Person's continued service relationship with the Issuer on the Vesting Date.
- [F2]Includes 11,250 RSUs and will be settled in common stock upon vesting. The RSUs vest in three successive, equal, annual installments measured from March 1, 2020, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date
- [F3]Includes 9,000 RSUs and will be settled in common stock upon vesting. The RSUs vest in four successive, equal, annual installments measured from January 19, 2019 subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date.
Documents
Issuer
Aimmune Therapeutics, Inc.
CIK 0001631650
Entity typeother
Related Parties
1- filerCIK 0001765473
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 5:20 PM ET
- Size
- 5.9 KB